Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tremoulet

Showing results (181-190 of 281) with videos related to

Pageof 29
Sort By:
The Pediatric Infectious Disease Journal|April 3, 2020
Paradoxical Antibiotic Effect of Ampicillin: Use of a Population Pharmacokinetic Model to Evaluate a Clinical Correlate of the Eagle Effect in Infants With BacteremiaJessica E Ericson, Christoph P Hornik, Rachel G Greenberg, et al.
Nature Communications|August 11, 2022
Publisher Correction: An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki diseasePradipta Ghosh, Gajanan D Katkar, Chisato Shimizu, et al.
Journal of the American Heart Association|May 18, 2026
Importance of Fostering International Collaboration for Optimal Outcomes of Kawasaki Disease Worldwide: A Science Advisory From the American Heart AssociationAshraf S Harahsheh, Shazia M Mohsin, Adriana Tremoulet, et al.
Circulation|April 11, 2022
SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults: A Scientific Statement From the American Heart AssociationPei-Ni Jone, Anitha John, Matthew E Oster, et al.
Nature Communications|May 16, 2022
An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki diseasePradipta Ghosh, Gajanan D Katkar, Chisato Shimizu, et al.
Plos One|March 14, 2013
Differential expression of miR-145 in children with Kawasaki diseaseChisato Shimizu, Jihoon Kim, Petra Stepanowsky, et al.
The Journal of Pediatrics|December 7, 2010
Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective studyMary Beth Son, Kimberlee Gauvreau, Jane C Burns, et al.
Genome Medicine|January 24, 2015
Global gene expression profiling identifies new therapeutic targets in acute Kawasaki diseaseLong Truong Hoang, Chisato Shimizu, Ling Ling, et al.
The Journal of Pediatrics|August 15, 2016
Electronic Health Records and Pharmacokinetic Modeling to Assess the Relationship between Ampicillin Exposure and Seizure Risk in NeonatesChristoph P Hornik, Daniel K Benjamin, P Brian Smith, et al.
Circulation Research|December 8, 2016
miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki DiseaseMing He, Zhen Chen, Marcy Martin, et al.
Pageof 29

Showing results (181-190 of 281) with videos related to

Sort By:
Pageof 29
The Pediatric Infectious Disease Journal|April 3, 2020
Paradoxical Antibiotic Effect of Ampicillin: Use of a Population Pharmacokinetic Model to Evaluate a Clinical Correlate of the Eagle Effect in Infants With BacteremiaJessica E Ericson, Christoph P Hornik, Rachel G Greenberg, et al.
Nature Communications|August 11, 2022
Publisher Correction: An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki diseasePradipta Ghosh, Gajanan D Katkar, Chisato Shimizu, et al.
Journal of the American Heart Association|May 18, 2026
Importance of Fostering International Collaboration for Optimal Outcomes of Kawasaki Disease Worldwide: A Science Advisory From the American Heart AssociationAshraf S Harahsheh, Shazia M Mohsin, Adriana Tremoulet, et al.
Circulation|April 11, 2022
SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults: A Scientific Statement From the American Heart AssociationPei-Ni Jone, Anitha John, Matthew E Oster, et al.
Nature Communications|May 16, 2022
An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki diseasePradipta Ghosh, Gajanan D Katkar, Chisato Shimizu, et al.
Plos One|March 14, 2013
Differential expression of miR-145 in children with Kawasaki diseaseChisato Shimizu, Jihoon Kim, Petra Stepanowsky, et al.
The Journal of Pediatrics|December 7, 2010
Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective studyMary Beth Son, Kimberlee Gauvreau, Jane C Burns, et al.
Genome Medicine|January 24, 2015
Global gene expression profiling identifies new therapeutic targets in acute Kawasaki diseaseLong Truong Hoang, Chisato Shimizu, Ling Ling, et al.
The Journal of Pediatrics|August 15, 2016
Electronic Health Records and Pharmacokinetic Modeling to Assess the Relationship between Ampicillin Exposure and Seizure Risk in NeonatesChristoph P Hornik, Daniel K Benjamin, P Brian Smith, et al.
Circulation Research|December 8, 2016
miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki DiseaseMing He, Zhen Chen, Marcy Martin, et al.
Pageof 29